XERS — Xeris Biopharma Holdings, Inc. stock price, charts and financials

QT65Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.19
+0.06+0.74%
OverviewShort InterestFilings
XERSQT65Xeris Biopharma Holdings, Inc.·NASDAQ
8.19+0.74%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Jul 31, 2026SC 13GBeneficial ownership statement (passive)
Jul 17, 20268-KCurrent report
Jul 07, 20264Statement of changes in beneficial ownership
Jul 02, 20263Initial statement of beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 30, 20268-KCurrent report
Jun 11, 20268-KCurrent report
Jun 05, 20268-KCurrent report
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
May 01, 20264Statement of changes in beneficial ownership
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 23, 2026ARSAnnual report to shareholders
#1 / 25 of 300
Page
▼
/ 12